Veracyte
VCYT
$20.35
Share price
0.79%
Change (1 day)
-5.44%
Change (1 year)
Categories
P/S ratio for Veracyte (VCYT)
P/S ratio as of May 2024 (TTM): 4.27
According to Veracyte's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.27496. At the end of 2023 the company had a P/S ratio of 5.57.
P/S ratio history for Veracyte from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.57 | -3.08% |
| 2022 | 5.74 | -56.94% |
| 2021 | 13.3 | -44.71% |
| 2020 | 24.1 | 109.53% |
| 2019 | 11.5 | 106.03% |
| 2018 | 5.59 | 80.86% |
| 2017 | 3.09 | -7.06% |
| 2016 | 3.32 | -17.45% |
| 2015 | 4.03 | -29.32% |
| 2014 | 5.70 | -59.33% |
| 2013 | 14.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | 4.45 | 4.15% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.31 | -45.99% | 🇺🇸 USA |
 Biocept
BIOC | -0.3324 | -107.78% | 🇺🇸 USA |